Finding the Goldilocks zone in neoadjuvant radioimmunotherapy

Famke L. Schneiders; Suresh Senan

doi:https://doi.org/10.1038/s41571-021-00540-x

Finding the Goldilocks zone in neoadjuvant radioimmunotherapy

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	545-546
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	18
Issue number	9
Early online date	5 Jul 2021
DOIs	https://doi.org/10.1038/s41571-021-00540-x https://doi.org/10.1038/s41571-021-00540-x
Publication status	Published - 1 Sept 2021

Access to Document

Cite this

@article{90338415561f43d488183e4828f7f93f,

title = "Finding the Goldilocks zone in neoadjuvant radioimmunotherapy",

author = "Schneiders, {Famke L.} and Suresh Senan",

note = "Funding Information: S.S. reports institutional grants and personal fees from AstraZeneca and Varian Medical Systems, institutional grants from Bristol Myers Squibb and ViewRay, and personal fees from BeiGene and MSD. S.S. is a member of the scientific steering committee of the European Thoracic Oncology Group. F.L.S. declares no competing interests. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = sep,

day = "1",

doi = "https://doi.org/10.1038/s41571-021-00540-x",

language = "English",

volume = "18",

pages = "545--546",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Finding the Goldilocks zone in neoadjuvant radioimmunotherapy

AU - Schneiders, Famke L.

AU - Senan, Suresh

N1 - Funding Information: S.S. reports institutional grants and personal fees from AstraZeneca and Varian Medical Systems, institutional grants from Bristol Myers Squibb and ViewRay, and personal fees from BeiGene and MSD. S.S. is a member of the scientific steering committee of the European Thoracic Oncology Group. F.L.S. declares no competing interests. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/9/1

Y1 - 2021/9/1

UR - http://www.scopus.com/inward/record.url?scp=85109854829&partnerID=8YFLogxK

U2 - https://doi.org/10.1038/s41571-021-00540-x

DO - https://doi.org/10.1038/s41571-021-00540-x

M3 - Article

C2 - 34226694

SN - 1759-4774

VL - 18

SP - 545

EP - 546

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

IS - 9

ER -

Finding the Goldilocks zone in neoadjuvant radioimmunotherapy

Access to Document

Other files and links

Cite this